Skip to main content
. Author manuscript; available in PMC: 2013 Jan 15.
Published in final edited form as: Blood Cells Mol Dis. 2011 Oct 7;48(1):25–29. doi: 10.1016/j.bcmd.2011.09.004

Figure 2.

Figure 2

Anti-ANGPTL-3, but not anti-ANGPTL-4, -6, or -7 neutralizes the survival enhancing effects of ANGPTL-3. Results are shown as the mean +/− 1SD for on experiment in which 500 CD34+ cord blood cells were plated per ml. ap<0.001 compared to day 0 control medium; b p<0.001 compared to day 1 control medium.